valuations across the agro chem space seem to attractively priced currently - just for context if we see the results from Bayer , Basf , GAVL etc : Risk to Reward seems favourable for Sumitomo Chem : one pertinent point ref Glyphosate hearing on 7th dec 23 company management believes that regulatory restrictions are unlikely
Subscribe To Our Free Newsletter |